Trial intelligence / Profile preview

Mannitol Challenge Test in Asthma Patients on Fixed Dose Combinations

NCT01449123Phase 4Completed

Sponsor
Mundipharma
Start
Sep 2011
Primary completion
Apr 2012
Modality
Inhalation Devices, Small Molecules
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Bronchitol in asthma, sponsored by Mundipharma. Primary endpoint: Mannitol challenge test (Aridol™) + short-acting β2-agonist - positive response at Day 1. Started Sep 2011; status: completed.

02

Drugs

Bronchitol
03

Conditions

asthma

Beyond the preview

Go deeper on NCT01449123.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01449123.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call